SI-BONE, Inc. Common Stock (SIBN) is a publicly traded Healthcare sector company. As of May 21, 2026, SIBN trades at $14.75 with a market cap of $654.60M and a P/E ratio of -19.64. SIBN moved -0.13% today. Year to date, SIBN is -25.79%; over the trailing twelve months it is -24.81%. Its 52-week range spans $11.48 to $21.89. Analyst consensus is strong buy with an average price target of $22.17. Rallies surfaces SIBN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
7 analysts cover SIBN: 0 strong buy, 7 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $22.17.
| Metric | Value |
|---|---|
| Price | $14.75 |
| Market Cap | $654.60M |
| P/E Ratio | -19.64 |
| EPS | $-0.75 |
| Dividend Yield | 0.00% |
| 52-Week High | $21.89 |
| 52-Week Low | $11.48 |
| Volume | 26 |
| Avg Volume | 0 |
| Revenue (TTM) | $167.18M |
| Net Income | $-30.91M |
| Gross Margin | 79.03% |
7 analysts cover SIBN: 0 strong buy, 7 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $22.17.